Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men
- PMID: 23220167
- PMCID: PMC3606681
- DOI: 10.1016/j.cgh.2012.11.028
Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men
Abstract
Background & aims: Abdominal obesity increases the risk of gastroesophageal reflux disease (GERD) and also might contribute to the development of Barrett's esophagus (BE), although results are inconsistent. We examined the effects of waist-to-hip ratio (WHR) and body mass index (BMI) on the risk of BE and investigated whether race, GERD symptoms, or hiatus hernia were involved.
Methods: We conducted a case-control study using data from eligible patients who underwent elective esophagogastroduodenoscopy; 237 patients had BE and the other 1021 patients served as endoscopy controls. We also analyzed data and tissue samples from enrolled patients who were eligible for screening colonoscopies at a primary care clinic (colonoscopy controls, n = 479). All patients underwent esophagogastroduodenoscopy, completed a survey, and had anthropometric measurements taken. WHR was categorized as high if it was 0.9 or greater for men or 0.85 or greater for women. Data were analyzed with logistic regression.
Results: There was no association between BMI and BE. However, more patients with BE had a high WHR (92.4%) than endoscopy controls (79.5%) or colonoscopy controls (84.6%) (P < .001 and P = .008, respectively). In adjusted analysis, patients with BE were 2-fold more likely to have a high WHR than endoscopy controls (odds ratio [OR], 1.93; 95% confidence interval [CI], 1.1-3.5), this association was stronger for patients with long-segment BE (OR, 2.81; 95% CI, 1.0-7.9). A high WHR was associated significantly with BE only in whites (OR, 2.5; 95% CI, 1.2-5.4), but not in blacks or Hispanics. GERD symptoms, hiatus hernia, or gastroesophageal valve flap grade could not account for the association.
Conclusions: High WHR, but not BMI, is associated with a significant increase in the risk of BE, especially long-segment BE and in whites. The association is not caused by GERD symptoms or hiatus hernia.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Abdominal obesity and body mass index as risk factors for Barrett's esophagus.Gastroenterology. 2007 Jul;133(1):34-41; quiz 311. doi: 10.1053/j.gastro.2007.04.046. Epub 2007 Apr 25. Gastroenterology. 2007. PMID: 17631128
-
Abdominal diameter index is a stronger predictor of prevalent Barrett's esophagus than BMI or waist-to-hip ratio.Dis Esophagus. 2017 Sep 1;30(9):1-6. doi: 10.1093/dote/dox056. Dis Esophagus. 2017. PMID: 28859359
-
Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans.Am J Gastroenterol. 2013 Oct;108(10):1576-83. doi: 10.1038/ajg.2013.222. Epub 2013 Jul 16. Am J Gastroenterol. 2013. PMID: 23857477 Free PMC article.
-
Risk factors in the development of esophageal adenocarcinoma.Am J Gastroenterol. 2013 Feb;108(2):200-7. doi: 10.1038/ajg.2012.387. Epub 2012 Dec 18. Am J Gastroenterol. 2013. PMID: 23247577
-
Risk factors for Barrett's esophagus compared between African Americans and non-Hispanic Whites.Am J Gastroenterol. 2014 Dec;109(12):1870-80. doi: 10.1038/ajg.2014.351. Epub 2014 Nov 25. Am J Gastroenterol. 2014. PMID: 25420546
Cited by
-
Personal and family history of cancer and the risk of Barrett's esophagus in men.Dis Esophagus. 2015 Apr;28(3):283-90. doi: 10.1111/dote.12185. Epub 2014 Feb 17. Dis Esophagus. 2015. PMID: 24529029 Free PMC article.
-
Impact of Obesity on a Chinese Population with Erosive Esophagitis and Barrett's Esophagus.Gut Liver. 2017 May 15;11(3):377-382. doi: 10.5009/gnl16211. Gut Liver. 2017. PMID: 27965477 Free PMC article.
-
Critical appraisal of guidelines for screening and surveillance of Barrett's esophagus.Ann Transl Med. 2018 Jul;6(13):259. doi: 10.21037/atm.2018.05.09. Ann Transl Med. 2018. PMID: 30094245 Free PMC article. Review.
-
Barrett's esophagus suspected at endoscopy but no specialized intestinal metaplasia on biopsy, what's next?Am J Gastroenterol. 2014 Feb;109(2):178-82. doi: 10.1038/ajg.2013.408. Epub 2013 Dec 17. Am J Gastroenterol. 2014. PMID: 24343550 Free PMC article.
-
Endoluminal therapies for Barrett's esophagus.Obes Surg. 2016 Apr;26(4):721-6. doi: 10.1007/s11695-015-2010-2. Obes Surg. 2016. PMID: 26670678 Review.
References
-
- Bollschweiler E, Wolfgarten E, Gutschow C, et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer. 2001;92:549–555. - PubMed
-
- Gerson LB, Edson R, Lavori PW, et al. Use of a simple symptom questionnaire to predict Barrett’s esophagus in patients with symptoms of gastroesophageal reflux. Am J Gastroenterol. 2001;96:2005–2012. - PubMed
-
- Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825–1831. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources